These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 4070302)

  • 21. The design and development of therapeutic agents for neuromuscular diseases.
    Lewis NJ
    Prog Clin Biol Res; 1985; 197():105-10. PubMed ID: 4070284
    [No Abstract]   [Full Text] [Related]  

  • 22. Orphan drugs: the question of products liability.
    Scharf SF
    Am J Law Med; 1985; 10(4):491-513. PubMed ID: 3911776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NIH epilepsy branch trials: budgetary and practical issues.
    Jacobs MP
    Epilepsy Res Suppl; 1993; 10():239-44. PubMed ID: 8251102
    [No Abstract]   [Full Text] [Related]  

  • 25. Adoption agent.
    Peota C
    Minn Med; 2005 Mar; 88(3):8-9. PubMed ID: 15852583
    [No Abstract]   [Full Text] [Related]  

  • 26. [Orphan drugs: some legal, ethical and economics aspects].
    Pabst JY
    Rev Epidemiol Sante Publique; 2001 Sep; 49(4):387-96. PubMed ID: 11567205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiepileptic drugs: future development.
    Porter RJ
    Epilepsy Res Suppl; 1993; 10():69-77. PubMed ID: 7504494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lucrative niches: how drugs for rare diseases became lifeline for companies.
    Anand G
    Wall St J (East Ed); 2005 Nov; ():A1, A18. PubMed ID: 16502531
    [No Abstract]   [Full Text] [Related]  

  • 29. Orphan drug development in the United States.
    Groft SC
    CPJ; 1985 May; 118(5):219-22. PubMed ID: 10271306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Developing drugs for developing countries.
    Ridley DB; Grabowski HG; Moe JL
    Health Aff (Millwood); 2006; 25(2):313-24. PubMed ID: 16522573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The new antiepileptic drugs: their indications and side effects].
    Malagón-Valdez J
    Rev Neurol; 2004 Sep 16-30; 39(6):570-5. PubMed ID: 15467997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Orphan drugs--medications for patients with rare diseases].
    Thielke D; Thyssen JP; Hansen BJ
    Ugeskr Laeger; 2006 Jun; 168(23):2236-8. PubMed ID: 16768975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiepileptic drug development program: a cooperative effort of government and industry.
    Kupferberg HJ
    Epilepsia; 1989; 30 Suppl 1():S51-6; discussion S64-8. PubMed ID: 2776711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NIH gives money for orphan development.
    Watanabe ME
    Nat Med; 2000 Nov; 6(11):1197-8. PubMed ID: 11062512
    [No Abstract]   [Full Text] [Related]  

  • 35. Anticonvulsant and neurotoxicity evaluation of new bromophthalimidobutyryl amide derivatives.
    Khan SA; Siddiqui N; Kamal M; Alam O; Jawaid T
    Acta Pol Pharm; 2009; 66(1):65-8. PubMed ID: 19226971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CMS move threatens to put orphan drugs out in cold.
    Carroll J
    Manag Care; 2003 Jul; 12(7):10-1. PubMed ID: 12891947
    [No Abstract]   [Full Text] [Related]  

  • 37. The Anticonvulsant Screening Program of the National Institute of Neurological Disorders and Stroke, NIH: History and Contributions to Clinical Care in the Twentieth Century and Beyond.
    Porter RJ; Kupferberg HJ
    Neurochem Res; 2017 Jul; 42(7):1889-1893. PubMed ID: 28275952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NCI cooperative research and development agreements.
    Ivy SP
    Oncology (Williston Park); 2000 Dec; 14(12 Suppl 11):27-9. PubMed ID: 11204659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carisbamate, a new carbamate for the treatment of epilepsy.
    Kulig K; Malawska B
    IDrugs; 2007 Oct; 10(10):720-7. PubMed ID: 17899491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rare diseases, drug development, and AIDS: the impact of the Orphan Drug Act.
    Arno PS; Bonuck K; Davis M
    Milbank Q; 1995; 73(2):231-52. PubMed ID: 7776947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.